103 related articles for article (PubMed ID: 9759699)
1. Combining volume-weighted mean nuclear volume with Gleason score and clinical stage to predict more reliably disease outcome of patients with prostate cancer.
Fujikawa K; Sasaki M; Itoh T; Arai Y; Ogawa O; Yoshida O
Prostate; 1998 Oct; 37(2):63-9. PubMed ID: 9759699
[TBL] [Abstract][Full Text] [Related]
2. The role of volume-weighted mean nuclear volume in predicting disease outcome in patients with prostate cancer treated with radical prostatectomy.
Fujikawa K; Itoh T; Nishio Y; Miyakawa M; Sasaki M
APMIS; 1999 Aug; 107(8):773-8. PubMed ID: 10515128
[TBL] [Abstract][Full Text] [Related]
3. Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume.
Fujikawa K; Sasaki M; Arai Y; Yamabe H; Ogawa O; Yoshida O
Clin Cancer Res; 1997 Apr; 3(4):613-8. PubMed ID: 9815728
[TBL] [Abstract][Full Text] [Related]
4. The role of volume-weighted mean nuclear volume in predicting disease outcome in patients with stage M1 prostate cancer.
Fujikawa K; Aoyama T; Itoh T; Nishio Y; Miyakawa M; Sasaki M
APMIS; 1999 Apr; 107(4):395-400. PubMed ID: 10230693
[TBL] [Abstract][Full Text] [Related]
5. Volume-weighted mean nuclear volume predicts tumor biology of clinically organ-confined prostate cancer.
Arai Y; Okubo K; Terada N; Matsuta Y; Egawa S; Kuwao S; Ogura K
Prostate; 2001 Feb; 46(2):134-41. PubMed ID: 11170141
[TBL] [Abstract][Full Text] [Related]
6. Predicting pathological stage of localized prostate cancer using volume weighted mean nuclear volume.
Fujikawa K; Matsui Y; Kobayashi T; Miura K; Oka H; Fukuzawa S; Takeuchi H
J Urol; 2000 Nov; 164(5):1587-90. PubMed ID: 11025710
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factor in patients with prostate cancer].
Fujikawa K; Aoyama T; Sasaki M
Nihon Hinyokika Gakkai Zasshi; 1995 Dec; 86(12):1745-50. PubMed ID: 8717215
[TBL] [Abstract][Full Text] [Related]
8. Prognostic criteria in patients with prostate cancer: correlation with volume weighted mean nuclear volume.
Fujikawa K; Sasaki M; Aoyama T; Itoh T; Yoshida O
J Urol; 1995 Dec; 154(6):2123-7. PubMed ID: 7500473
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of nuclear morphometry on needle biopsy from patients with prostate cancer: is volume-weighted mean nuclear volume superior to other morphometric parameters?
Zhang YH; Kanamaru H; Oyama N; Miwa Y; Suzuki Y; Akino H; Noriki S; Okada K
Urology; 2000 Mar; 55(3):377-81. PubMed ID: 10699614
[TBL] [Abstract][Full Text] [Related]
10. Prognostic criteria in patients with stage D2 prostate cancer. Correlation with mean nuclear volume.
Fujikawa K; Sasaki M; Aoyama T; Itoh T
Cancer; 1995 Jul; 76(1):91-5. PubMed ID: 8630882
[TBL] [Abstract][Full Text] [Related]
11. The role of volume-weighted mean nuclear volume in predicting tumour biology and clinical behaviour in patients with prostate cancer undergoing watchful waiting.
Arai Y; Egawa S; Kuwao S; Ogura K; Baba S
BJU Int; 2001 Dec; 88(9):909-14. PubMed ID: 11851612
[TBL] [Abstract][Full Text] [Related]
12. Volume-weighted mean nuclear volume. Is this new prognosticator comparable in different institutions?
Fujikawa K; Aoyama T; Itoh T; Nishio Y; Miyakawa M; Sasaki M
Anal Quant Cytol Histol; 2000 Feb; 22(1):55-62. PubMed ID: 10696461
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification after radical prostatectomy in men with pathologically organ-confined prostate cancer using volume-weighted mean nuclear volume.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Prostate; 2005 Aug; 64(3):217-23. PubMed ID: 15712275
[TBL] [Abstract][Full Text] [Related]
14. Stereologically estimated mean nuclear volume of prostatic cancer is a reliable prognostic parameter.
Arima K; Sugimura Y; Hioki T; Yamashita A; Kawamura J
Br J Cancer; 1997; 76(2):234-7. PubMed ID: 9231924
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of DNA ploidy and nuclear morphometry in prostate cancer treated with androgen deprivation.
Martínez-Jabaloyas JM; Ruiz-Cerdá JL; Hernández M; Jiménez A; Jiménez-Cruz F
Urology; 2002 May; 59(5):715-20. PubMed ID: 11992846
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral heterogeneity in prostate cancer demonstrated by volume-weighted mean nuclear volume.
Fujikawa K; Sasaki M; Aoyama T; Itoh T; Yoshida O
APMIS; 1997 Apr; 105(4):322-8. PubMed ID: 9164477
[TBL] [Abstract][Full Text] [Related]
17. Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control.
Kaminski JM; Hanlon AL; Horwitz EM; Pinover WH; Mitra RK; Hanks GE
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):888-92. PubMed ID: 11958880
[TBL] [Abstract][Full Text] [Related]
18. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
19. Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.
Partin AW; Steinberg GD; Pitcock RV; Wu L; Piantadosi S; Coffey DS; Epstein JI
Cancer; 1992 Jul; 70(1):161-8. PubMed ID: 1606538
[TBL] [Abstract][Full Text] [Related]
20. Impact of volume weighted mean nuclear volume on outcomes following salvage radiation therapy after radical prostatectomy.
Matsui Y; Ichioka K; Terada N; Yoshimura K; Terai A; Dodo Y; Arai Y
J Urol; 2004 Feb; 171(2 Pt 1):687-91. PubMed ID: 14713787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
